UPDATE 3-U.S. FDA approves Bristol-Myers MS drug, launch delayed due to coronavirus
March 26, 2020 at 08:57 AM EDT
Bristol-Myers Squibb Co said on Thursday the U.S. Food and Drug Administration approved its multiple sclerosis (MS) treatment, Zeposia, but the launch would be delayed due to the coronavirus outbreak.
